Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Wedbush Analyst Recommends Holding Super Micro Computer Stock

Elaine Mendonca by Elaine Mendonca
January 19, 2024
in Breaking News
0
Information Technology Stock Market Today
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On January 19, 2024, Wedbush analyst Matt Bryson expressed his stance on Super Micro Computer (NASDAQ: SMCI), reiterating a Neutral rating and affirming a price target of $250. Rather than advocating for buying or selling the stock, Bryson advises holding onto it. His price target implies that he perceives the stock to be reasonably valued at that particular level. It is crucial to evaluate this insight in relation to your personal investment objectives and tolerance for risk.

SMCI Stock Analysis: Positive Momentum Despite Recent Drop – Investors Should Monitor Pre-Market Rise

On January 19, 2024, SMCI stock displayed some interesting price movements. According to data sourced from CNN Money, SMCI was trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock was exhibiting positive price momentum.

However, the price of SMCI shares experienced a decline of $6.79 since the market last closed, representing a drop of 2.13%. The stock had closed at $311.44.

Despite this drop, there was some positive news in pre-market trading, as the stock managed to rise by $31.57.

Investors should closely monitor SMCI’s stock performance in the upcoming trading session to see if the pre-market rise can be sustained. It will be important to assess whether this increase is a temporary fluctuation or a sign of a potential upward trend.

As always, it is crucial for investors to conduct thorough research and analysis before making any investment decisions. Factors such as the company’s financial health, industry trends, and overall market conditions should all be taken into consideration.

SMCI Stock Shows Impressive Growth in Q1 2024: Total Revenue, Net Income, and EPS Soar

SMCI Stock Shows Strong Performance in Q1 2024

On January 19, 2024, SMCI stock demonstrated a solid performance, driven by its impressive financial results for the past year and first quarter. The data, sourced from CNN Money, highlights the company’s remarkable growth in total revenue, net income, and earnings per share.

Starting with total revenue, SMCI reported a significant increase of 37.09% over the past year, reaching an impressive $7.12 billion. This growth demonstrates the company’s ability to expand its market presence and capture a larger share of the industry. Additionally, it is worth noting that the total revenue remained flat since the previous quarter, indicating a stable performance.

In terms of net income, SMCI showcased remarkable growth, with a 124.43% increase since last year. The company reported a net income of $640.00 million, showcasing its ability to generate substantial profits. However, there was a slight decline of 18.89% in net income since the previous quarter. Despite this decrease, the overall trend remains positive, suggesting a strong financial performance for the company.

Earnings per share (EPS) also experienced a significant increase over the past year, rising by 114.99% to reach $11.43. This growth indicates that SMCI has been successful in increasing its profitability on a per-share basis. However, there was a decline of 19.86% in EPS since the previous quarter. While this decrease may raise some concerns, it is important to consider the overall upward trend in EPS, which showcases the company’s ability to generate consistent returns for its shareholders.

Overall, SMCI’s stock performance on January 19, 2024, was impressive, reflecting the company’s strong financial performance. The significant growth in total revenue, net income, and earnings per share over the past year demonstrates SMCI’s ability to thrive in the market. Despite a slight decline in net income and EPS since the previous quarter, the overall trend remains positive, indicating a promising future for SMCI and its shareholders.

Tags: SMCI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ projections

Goldman Sachs Analyst Maintains Buy Rating on Discover Financial Services with Adjusted Price Target

Finance_ Stock Trading (2)

Goldman Sachs Analyst Maintains Neutral Rating for Booking Holdings with Increased Price Target

Biotechnology Stock Bull Market

Decrease in Short Interest Indicates a Shift in Market Sentiment for Kyndryl Hldgs

Recommended

The Trade Desk Stock

The Trade Desk Bets Big on AI to Reshape Digital Advertising

1 month ago
SO stock news

Progressive Corporations Remarkable Financial Performance Drives Surge in Stock Price

2 years ago
Consumer Goods Stock Market Today

Analyst Sentiments and Price Targets for Church Dwight Co NYSECHD

2 years ago
Finances

Investor Sentiment and Options Activity for Halliburton on March 15 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

L3Harris Shares Show Strength Amid Mixed Signals

Cytokinetics Faces Critical FDA Decision and Financial Pressure

BAE Systems Shares Maintain Strong Trajectory Amid Major Defense Contracts

Why Going Private Was the Only Viable Path for Focus Financial

CrowdStrike Shares Surge as AI Security Demand Intensifies

Ford Stock Ignites as Strategic Shift and Strong Earnings Impress Investors

Trending

Adobe Stock
AI & Quantum Computing

Adobe’s AI Promise Clashes With Stock Market Reality

by Dieter Jaworski
November 6, 2025
0

While Adobe generates billions in revenue from artificial intelligence initiatives, the software giant's stock performance tells a...

Bristol-Myers Squibb Stock

Bristol-Myers Squibb Navigates Financial and Legal Challenges Amid Strong Performance

November 6, 2025
Canaan Stock

Canaan Stock Surges on Triple Catalyst Boost

November 6, 2025
L3Harris Stock

L3Harris Shares Show Strength Amid Mixed Signals

November 6, 2025
Cytokinetics Stock

Cytokinetics Faces Critical FDA Decision and Financial Pressure

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Adobe’s AI Promise Clashes With Stock Market Reality
  • Bristol-Myers Squibb Navigates Financial and Legal Challenges Amid Strong Performance
  • Canaan Stock Surges on Triple Catalyst Boost

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com